Successful treatment of cutaneous mucormycosis after renal transplantation by debridement, liposomal amphotericin B, and isavuconazole

Successful treatment of cutaneous mucormycosis after renal transplantation by debridement, liposomal amphotericin B, and isavuconazole

Bibliographic Details
Main Authors:	Balaji Kirushnan, R Balasubramaniyam, Anu Ramesh, M Jeevagan, Vijayalakshmi Balakrishnan
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Indian Journal of Transplantation
Online Access:	http://www.ijtonline.in/article.asp?issn=2212-0017;year=2023;volume=17;issue=4;spage=470;epage=471;aulast=Kirushnan

Similar Items

Early-onset inflammatory bowel disease after renal transplantation - A case report
by: Balaji Kirushnan, et al.
Published: (2021-01-01)

Successful Multimodal Therapy with Intracerebral Liposomal Amphotericin B and Systemic High-Dose Isavuconazole in Proven Disseminated Aspergillosis
by: Simon Feys, et al.
Published: (2023-03-01)

In Vitro Activity of Isavuconazole and Amphotericin B in Association against Mucorales
by: Gaia Ortalli, et al.
Published: (2023-07-01)

Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B
by: Maria Ubals, et al.
Published: (2021-09-01)

Efficacy of combination therapy of amphotericin and posaconazole in treatment of mucormycosis
by: Sridhara S, et al.
Published: (2023-03-01)

Mucormycosis: Effect of Comorbidities and Repeated Debridement on the Outcome
by: Harshavardhan N Reddy, et al.
Published: (2019-04-01)

Mucormycosis: Effect of Comorbidities and Repeated Debridement on the Outcome
by: Harshavardhan N Reddy, et al.
Published: (2019-04-01)

Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy
by: Jenks JD, et al.
Published: (2018-04-01)

A Berry and Acute Kidney Injury
by: B Balaji Kirushnan, et al.
Published: (2022-01-01)

Liver and renal function profile of mucormycosis cases receiving amphotericin B - A retrospective study
by: Bhoomi Bavadiya, et al.
Published: (2022-01-01)

Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes
by: Guilherme S. Ramos, et al.
Published: (2022-05-01)

Is 24 hours infusion of Amphotericin B deoxycholate as good as liposomal Amphotericin B?
by: Swiss Medical Weekly
Published: (2002-08-01)

Survival of a Rhino-Orbital-Cerebral Mucormycosis Patient after Localized Combination Liposomal Amphotericin B Medications: A Case Report
by: Yang Zhou
Published: (2024-02-01)

Successful treatment of rhino-cerebral mucormycosis with dual antifungal therapy and minimal surgical debridement
by: Lauren Bougioukas, et al.
Published: (2022-01-01)

Amphotericin B colloidal dispersion: an effective drug for the treatment of mucormycosis in China
by: Juntao Liu, et al.
Published: (2023-05-01)

Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis
by: Ramesh Murthy, et al.
Published: (2022-01-01)

Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B
by: Nur Efe İris, et al.
Published: (2016-11-01)

Liposomal amphotericin B in drug-resistant visceral leishmaniasis.
by: Davidson, R, et al.
Published: (1991)

Methods for particle size reduction of liposomal amphotericin B
by: Tuan Quang Nguyen, et al.
Published: (2018-03-01)

Rhino–Orbito–Cerebral Mucormycosis Resistant to Amphotericin B: Two Diabetic Cases
by: Esma Eren, et al.
Published: (2019-09-01)

Mucormycosis Management in COVID-19 Era: Is Immediate Surgical Debridement and Reconstruction the Answer?
by: Samarth Gupta, et al.
Published: (2022-05-01)

Posaconazole or isavuconazole as sole or predominant antifungal therapy for COVID-19-associated mucormycosis. A retrospective observational case series
by: Rajeev Soman, et al.
Published: (2022-07-01)

Primary cutaneous mucormycosis of the scalp
by: Bommie Florence Seo, et al.
Published: (2021-09-01)

Combination endoscopic surgical debridement and transcutaneous retrobulbar amphotericin B for acute rhino-orbital-cerebral aspergillosis
by: Kevin X. Zhang, et al.
Published: (2023-12-01)

Field Efficacy of Topical Nano-Liposomal Amphotericin B (Sina Ampholeish®) Alone or in Combination with Glucantime® and Cryotherapy on Human Cutaneous Leishmaniasis
by: Zahra Alizadeh, et al.
Published: (2023-11-01)

Long-term outcomes of transcutaneous retrobulbar amphotericin B in COVID-19-associated mucormycosis
by: Syed Wajahat A Rizvi, et al.
Published: (2023-01-01)

Recovery from anaesthesia in post-COVID-19 mucormycosis debridement surgery: An observational study
by: Roopa Sachidananda, et al.
Published: (2022-01-01)

Isavuconazole for Treating Invasive Mould Disease in Solid Organ Transplant Recipients
by: Jose Tiago Silva, et al.
Published: (2023-12-01)

Mucormycosis with Orbital Apex Syndrome in a Renal Transplant Recipient
by: Ebru Kursun, et al.
Published: (2015-06-01)

Repurposing Amphotericin B and Its Liposomal Formulation for the Treatment of Human Mpox
by: Daniela Peruzzu, et al.
Published: (2023-05-01)

Direct transbronchial administration of liposomal amphotericin B into a pulmonary aspergilloma
by: Takayuki Takeda, et al.
Published: (2014-01-01)

Different liposomal amphotericin B formulations for visceral leishmaniasis–Author's reply
by: Nilima Kshirsagar
Published: (2014-08-01)

Isavuconazole Pharmacokinetics and Pharmacodynamics in Children
by: Hirsh Elhence, et al.
Published: (2022-12-01)

Immediate hypersensitivity reaction following liposomal amphotericin-B (AmBisome) infusion.
by: Nath, P, et al.
Published: (2014)

Global Cutaneous Mucormycosis: A Systematic Review
by: Anna Skiada, et al.
Published: (2022-02-01)

Isavuconazole—Animal Data and Clinical Data
by: Livio Pagano, et al.
Published: (2020-10-01)

Isolated renal allograft mucormycosis
by: Aditya A Pradhan, et al.
Published: (2006-01-01)

Comparison of the Efficacies of Topical Liposomal Amphotericin B and Topical Clotrimazole in the Treatment of Pityriasis Versicolor
by: Mehdi Ghahartars, et al.
Published: (2024-01-01)

Liposomal and Deoxycholate Amphotericin B Formulations: Effectiveness against Biofilm Infections of Candida spp.
by: Célia F. Rodrigues, et al.
Published: (2017-12-01)

Persistent dyselectrolytemia in a neonate induced by liposomal amphotericin B. A case report
by: Adrian Puertas Sanjuan, et al.
Published: (2023-01-01)